U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 184

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr6:32007182
GRCh38:
Chr6:32039405
CYP21A2, LOC106780800S136C, S166C, S31CClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(Apr 17, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr6:32006290
GRCh38:
Chr6:32038513
CYP21A2, LOC106780800P31SClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(Apr 14, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr6:32006236
GRCh38:
Chr6:32038459
CYP21A2, LOC106780800L13MClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(Jan 20, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr6:32006303
GRCh38:
Chr6:32038526
CYP21A2, LOC106780800P35LClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(Jan 20, 2023)
criteria provided, single submitter
5.
GRCh37:
Chr6:32007587
Chr6:32007584
GRCh38:
Chr6:32039810
Chr6:32039807
CYP21A2, LOC106780800, LOC106780800, CYP21A2V238E, V103E, V208E, I237N, I207N, I102NCongenital adrenal hyperplasiaPathogenic
(Oct 19, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr6:32007587
Chr6:32007593
GRCh38:
Chr6:32039810
Chr6:32039816
CYP21A2, LOC106780800, LOC106780800, CYP21A2V238E, V103E, V208E, M240K, M105K, M210Knot specifiedUncertain significance
(Oct 19, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr6:32007593
Chr6:32007584
GRCh38:
Chr6:32039816
Chr6:32039807
LOC106780800, CYP21A2, LOC106780800, CYP21A2M240K, M105K, M210K, I237N, I207N, I102Nnot specifiedUncertain significance
(Oct 19, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr6:32007188
GRCh38:
Chr6:32039411
CYP21A2, LOC106780800L138P, L168P, L33PClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(Sep 1, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr6:32007387
GRCh38:
Chr6:32039610
CYP21A2, LOC106780800W175*, W205*, W70*Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(Sep 1, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr6:32006919
GRCh38:
Chr6:32039142
CYP21A2, LOC106780800S114F, S84FClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(Sep 1, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr6:32007009
GRCh38:
Chr6:32039232
CYP21A2, LOC106780800Q10fs, Q115fs, Q145fsClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyPathogenic
(May 22, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr6:32006589
GRCh38:
Chr6:32038812
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(May 22, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr6:32007960
GRCh38:
Chr6:32040183
CYP21A2, LOC106780800L173fs, L278fs, L308fsClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyPathogenic
(May 4, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr6:32008342
GRCh38:
Chr6:32040565
CYP21A2, LOC106780800R232C, R337C, R367CCongenital adrenal hyperplasia, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyConflicting interpretations of pathogenicity
(Mar 2, 2022)
criteria provided, conflicting interpretations
15.
GRCh37:
Chr6:32008540
GRCh38:
Chr6:32040763
CYP21A2, LOC106780800F270S, F375S, F405SClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(Mar 10, 2021)
criteria provided, single submitter
16.
GRCh37:
Chr6:32007962
GRCh38:
Chr6:32040185
CYP21A2, LOC106780800F172V, F277V, F307Vnot provided, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyConflicting interpretations of pathogenicity
(Feb 7, 2022)
criteria provided, conflicting interpretations
17.
GRCh37:
Chr6:32007956
GRCh38:
Chr6:32040179
CYP21A2, LOC106780800V170M, V275M, V305MClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(Mar 10, 2021)
criteria provided, single submitter
18.
GRCh37:
Chr6:32006951
GRCh38:
Chr6:32039174
CYP21A2, LOC106780800R125C, R95CClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(Mar 10, 2021)
criteria provided, single submitter
19.
GRCh37:
Chr6:32008313
GRCh38:
Chr6:32040536
CYP21A2, LOC106780800R222Q, R327Q, R357Qnot provided, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyConflicting interpretations of pathogenicity
(Jun 3, 2022)
criteria provided, conflicting interpretations
20.
GRCh37:
Chr6:32008330
GRCh38:
Chr6:32040553
CYP21A2, LOC106780800A228P, A333P, A363PClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(Mar 10, 2021)
criteria provided, single submitter
21.
GRCh37:
Chr6:32008306
GRCh38:
Chr6:32040529
CYP21A2, LOC106780800R220C, R325C, R355CClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(Mar 10, 2021)
criteria provided, single submitter
22.
GRCh37:
Chr6:32007612
GRCh38:
Chr6:32039835
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(Mar 10, 2021)
criteria provided, single submitter
23.
GRCh37:
Chr6:32008307
GRCh38:
Chr6:32040530
CYP21A2, LOC106780800R325P, R355P, R220PClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(Mar 10, 2021)
criteria provided, single submitter
24.
GRCh37:
Chr6:32007878
GRCh38:
Chr6:32040101
CYP21A2, LOC106780800E249K, E279K, E144KClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(Mar 10, 2021)
criteria provided, single submitter
25.
GRCh37:
Chr6:32008362
GRCh38:
Chr6:32040585
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(Mar 10, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr6:32007987
GRCh38:
Chr6:32040210
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(Mar 10, 2021)
criteria provided, single submitter
27.
GRCh37:
Chr6:32006982
GRCh38:
Chr6:32039205
CYP21A2, LOC106780800M136fs, M106fsClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(Mar 10, 2021)
criteria provided, single submitter
28.
GRCh37:
Chr6:32007525
GRCh38:
Chr6:32039748
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(Mar 10, 2021)
criteria provided, single submitter
29.
GRCh37:
Chr6:32008262
GRCh38:
Chr6:32040485
CYP21A2, LOC106780800R205H, R310H, R340HClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyPathogenic
(Jul 26, 2023)
criteria provided, single submitter
30.
GRCh37:
Chr6:32008318
GRCh38:
Chr6:32040541
CYP21A2, LOC106780800V224I, V329I, V359Inot providedUncertain significance
(Jul 29, 2021)
criteria provided, single submitter
31.
CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(Jul 21, 2021)
criteria provided, single submitter
32.
GRCh37:
Chr15:51504638
GRCh38:
Chr15:51212441
CYP19A1, MIR4713HG, PIRC66D381VClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significancecriteria provided, single submitter
33.
GRCh37:
Chr6:32008285
GRCh38:
Chr6:32040508
CYP21A2, LOC106780800A213T, A318T, A348TClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogeniccriteria provided, single submitter
34.
GRCh37:
Chr6:32006342
GRCh38:
Chr6:32038565
CYP21A2, LOC106780800Y48CClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(Sep 24, 2021)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr6:32008874
GRCh38:
Chr6:32041097
CYP21A2, LOC106780800R349P, R454P, R484Pnot provided, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyConflicting interpretations of pathogenicity
(May 22, 2022)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr6:32008697
GRCh38:
Chr6:32040920
CYP21A2, LOC106780800G290V, G395V, G425VClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogeniccriteria provided, single submitter
37.
GRCh37:
Chr6:32007875-32007876
GRCh38:
Chr6:32040098-32040099
CYP21A2, LOC106780800E144fs, E249fs, E279fsClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyPathogenic
(May 18, 2021)
no assertion criteria provided
38.
GRCh37:
Chr6:32007426
GRCh38:
Chr6:32039649
LOC106780800, CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyPathogenic
(May 18, 2021)
no assertion criteria provided
39.
GRCh37:
Chr6:32006239
GRCh38:
Chr6:32038462
CYP21A2, LOC106780800A14SClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 11, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr6:32008363
GRCh38:
Chr6:32040586
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyPathogenic
(Apr 23, 2021)
criteria provided, single submitter
41.
GRCh37:
Chr6:32008313
GRCh38:
Chr6:32040536
CYP21A2, LOC106780800R222P, R327P, R357PClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, not providedConflicting interpretations of pathogenicity
(Mar 10, 2021)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr6:32006087
GRCh38:
Chr6:32038310
LOC106780800, LOC110631417, CYP21A2Congenital adrenal hyperplasiaLikely pathogenic
(Mar 16, 2023)
criteria provided, single submitter
43.
GRCh37:
Chr7:75612803
GRCh38:
Chr7:75983485
LOC126860075, PORnot provided, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign/Likely benign
(Mar 3, 2015)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr6:32007846
GRCh38:
Chr6:32040069
CYP21A2, LOC106780800P133L, P238L, P268Lnot provided, not specified, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Benign/Likely benign
(Dec 10, 2021)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr6:32008696
GRCh38:
Chr6:32040919
CYP21A2, LOC106780800G290S, G425S, G395SClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, not providedPathogenic/Likely pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr6:32007840
GRCh38:
Chr6:32040063
CYP21A2, LOC106780800A236V, A266V, A131Vnot specified, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyConflicting interpretations of pathogenicity
(Feb 15, 2023)
criteria provided, conflicting interpretations
47.
GRCh37:
Chr6:32007370
GRCh38:
Chr6:32039593
CYP21A2, LOC106780800L64F, L199F, L169FClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, not providedConflicting interpretations of pathogenicity
(May 28, 2019)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr6:32007893
GRCh38:
Chr6:32040116
CYP21A2, LOC106780800M254V, M284V, M149Vnot provided, Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(Mar 17, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr6:32007825
GRCh38:
Chr6:32040048
LOC106780800, CYP21A2M126T, M231T, M261TClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(May 24, 2019)
no assertion criteria provided
50.
GRCh37:
Chr6:32007825
GRCh38:
Chr6:32040048
LOC106780800, CYP21A2M126R, M231R, M261RClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(May 24, 2019)
no assertion criteria provided
51.
GRCh37:
Chr6:32007797
GRCh38:
Chr6:32040020
CYP21A2, LOC106780800G117S, G222S, G252SClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(May 24, 2019)
no assertion criteria provided
52.
GRCh37:
Chr6:32007708
GRCh38:
Chr6:32039931
LOC106780800, CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
53.
GRCh37:
Chr6:32007687
GRCh38:
Chr6:32039910
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 22, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr6:32007598
GRCh38:
Chr6:32039821
CYP21A2, LOC106780800L107V, L212V, L242VClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
55.
GRCh37:
Chr6:32007521
GRCh38:
Chr6:32039744
LOC106780800, CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
56.
GRCh37:
Chr6:32007459
GRCh38:
Chr6:32039682
LOC106780800, CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
57.
GRCh37:
Chr6:32007454
GRCh38:
Chr6:32039677
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
58.
GRCh37:
Chr6:32007332
GRCh38:
Chr6:32039555
LOC106780800, CYP21A2L157V, L187V, L52VClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyLikely pathogenic
(May 24, 2019)
no assertion criteria provided
59.
GRCh37:
Chr6:32007304
GRCh38:
Chr6:32039527
LOC106780800, CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
60.
GRCh37:
Chr6:32007225
GRCh38:
Chr6:32039448
LOC106780800, CYP21A2D150E, D180E, D45EClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
61.
GRCh37:
Chr6:32007210
GRCh38:
Chr6:32039433
LOC106780800, CYP21A2Y145*, Y175*, Y40*Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyPathogenic
(May 24, 2019)
no assertion criteria provided
62.
GRCh37:
Chr6:32007194
GRCh38:
Chr6:32039417
CYP21A2, LOC106780800C140Y, C170Y, C35YClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyPathogenic
(May 24, 2019)
no assertion criteria provided
63.
GRCh37:
Chr6:32007185
GRCh38:
Chr6:32039408
LOC106780800, CYP21A2L137R, L167R, L32RClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
64.
GRCh37:
Chr6:32007184
GRCh38:
Chr6:32039407
LOC106780800, CYP21A2L137V, L167V, L32VClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
65.
GRCh37:
Chr6:32007170
GRCh38:
Chr6:32039393
LOC106780800, CYP21A2E132G, E162G, E27GClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
66.
GRCh37:
Chr6:32007130
GRCh38:
Chr6:32039353
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
67.
GRCh37:
Chr6:32007083
GRCh38:
Chr6:32039306
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
68.
GRCh37:
Chr6:32007064
GRCh38:
Chr6:32039287
LOC106780800, CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
69.
GRCh37:
Chr6:32007063
GRCh38:
Chr6:32039286
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
70.
GRCh37:
Chr6:32006983
GRCh38:
Chr6:32039206
LOC106780800, CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
71.
GRCh37:
Chr6:32006960
GRCh38:
Chr6:32039183
LOC106780800, CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
72.
GRCh37:
Chr6:32006900
GRCh38:
Chr6:32039123
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
73.
GRCh37:
Chr6:32008929
GRCh38:
Chr6:32041152
CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
74.
GRCh37:
Chr6:32008913
GRCh38:
Chr6:32041136
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
75.
GRCh37:
Chr6:32008869-32008870
GRCh38:
Chr6:32041092-32041093
CYP21A2, LOC106780800R349fs, R484fs, R454fsnot providedLikely pathogenic
(Apr 3, 2019)
criteria provided, single submitter
76.
GRCh37:
Chr6:32008870
GRCh38:
Chr6:32041093
LOC106780800, CYP21A2P348T, P453T, P483TClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
77.
GRCh37:
Chr6:32008828
GRCh38:
Chr6:32041051
CYP21A2, LOC106780800S334G, S439G, S469GClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
78.
GRCh37:
Chr6:32008794
GRCh38:
Chr6:32041017
LOC106780800, CYP21A2D322E, D427E, D457EClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
79.
GRCh37:
Chr6:32008743
GRCh38:
Chr6:32040966
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
80.
GRCh37:
Chr6:32008721
GRCh38:
Chr6:32040944
CYP21A2, LOC106780800P298R, P403R, P433RClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
81.
GRCh37:
Chr6:32008714
GRCh38:
Chr6:32040937
LOC106780800, CYP21A2G296S, G401S, G431SClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyPathogenic
(May 24, 2019)
no assertion criteria provided
82.
GRCh37:
Chr6:32008695
GRCh38:
Chr6:32040918
CYP21A2, LOC106780800C289*, C394*, C424*Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyPathogenic
(May 24, 2019)
no assertion criteria provided
83.
GRCh37:
Chr6:32008643
GRCh38:
Chr6:32040866
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
84.
GRCh37:
Chr6:32008625
GRCh38:
Chr6:32040848
LOC106780800, TNXB, CYP21A2not providedLikely benign
(May 23, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr6:32008527
GRCh38:
Chr6:32040750
LOC106780800, CYP21A2R266G, R371G, R401GClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
86.
GRCh37:
Chr6:32008496
GRCh38:
Chr6:32040719
LOC106780800, CYP21A2Q255H, Q360H, Q390HClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
87.
GRCh37:
Chr6:32008458
GRCh38:
Chr6:32040681
CYP21A2, LOC106780800D243Y, D348Y, D378Ynot specifiedUncertain significance
(Apr 24, 2023)
criteria provided, single submitter
88.
GRCh37:
Chr6:32008352
GRCh38:
Chr6:32040575
LOC106780800, CYP21A2R235P, R340P, R370PClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
89.
GRCh37:
Chr6:32007899
GRCh38:
Chr6:32040122
CYP21A2, LOC106780800A151S, A256S, A286SClassic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
90.
GRCh37:
Chr6:32006791
GRCh38:
Chr6:32039014
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
91.
GRCh37:
Chr6:32006783
GRCh38:
Chr6:32039006
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
92.
GRCh37:
Chr6:32006782
GRCh38:
Chr6:32039005
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
93.
GRCh37:
Chr6:32006780
GRCh38:
Chr6:32039003
LOC106780800, CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
94.
GRCh37:
Chr6:32006777
GRCh38:
Chr6:32039000
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
95.
GRCh37:
Chr6:32006776
GRCh38:
Chr6:32038999
LOC106780800, CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
96.
GRCh37:
Chr6:32006775
GRCh38:
Chr6:32038998
LOC106780800, CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
97.
GRCh37:
Chr6:32006756
GRCh38:
Chr6:32038979
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
98.
GRCh37:
Chr6:32006741
GRCh38:
Chr6:32038964
LOC106780800, CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyBenign
(May 24, 2019)
no assertion criteria provided
99.
GRCh37:
Chr6:32006771-32006772
GRCh38:
Chr6:32038994-32038995
LOC106780800, CYP21A2Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
100.
GRCh37:
Chr6:32006739-32006740
GRCh38:
Chr6:32038962-32038963
CYP21A2, LOC106780800Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyUncertain significance
(May 24, 2019)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination